Ignite Creation Date:
2024-05-06 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05203445
Status:
RECRUITING
Last Update Posted:
2024-01-25
First Post:
2022-01-10
Brief Title:
A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer TNBC or Hormone Receptor-positive HER2-negative Breast Cancer
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center